Membership
Courtside seats could be yours...

Topics

Valeant Pharmaceuticals International
Pharmaceutical giant Actavis plans to rename itself Allergan
Pharmaceutical giant Actavis plans to rename itself Allergan

Irish pharmaceutical company Actavis said it will adopt the Allergan name after closing a deal to buy the Irvine Botox maker. In November, Actavis agreed to pay about $66 billion in cash and stock to acquire Allergan, outbidding Canadian company Valeant Pharmaceuticals International Inc. for the Orange County firm. "By adopting the Allergan name for the corporation we will ensure that our corporate identity reflects the dramatic evolution of our company within the pharmaceutical industry," said Brent Saunders, chief executive of Actavis. "We are convinced that the Allergan name will provide an umbrella of exceptional brand equity for an expanded and even more relevant...

Loading